Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Avigen, Inc.
Avigen to Present at Needham & Company Biotechnology and Medical Technology Conference
June 21st, 2008
Avigen, Inc. (Nasdaq: AVGN), a biopharmaceutical company innovating therapeutics for neurological care, announced that President and CEO Kenneth Chahine will present information on Avigen's development programs and product pipeline at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference. Dr. Chahine will present on Thursday, June 12, from 11:00-11:30 a.m. ET at the New York Palace Hotel, New York City. Dr. Chahine's presentation will be webcast live and archived on Avigen's website at www.avigen.com. About Avigen Avigen is a biopharmaceutical company focused on unique small molecule therapeutics and...
Source: Law & Health Weekly (2008-06-21)
|
